Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marina Y. Konopleva"'
Autor:
Courtney D. DiNardo, Curtis A. Lachowiez, Koichi Takahashi, Sanam Loghavi, Tapan Kadia, Naval Daver, Lianchun Xiao, Maria Adeoti, Nicholas J. Short, Koji Sasaki, Sa A. Wang, Gautam Borthakur, Ghayas Issa, Abhishek Maiti, Yesid Alvarado, Naveen Pemmaraju, Guillermo Montalban Bravo, Lucia Masarova, Musa Yilmaz, Nitin Jain, Michael Andreeff, Guillermo Garcia‐Manero, Steven Kornblau, Farhad Ravandi, Elias Jabbour, Marina Y. Konopleva, Hagop M. Kantarjian
Publikováno v:
American journal of hematologyREFERENCES. 97(8)
Background: Multiagent induction chemotherapy consisting of fludarabine, cytarabine, G-CSF, and idarubicin (FLAG-IDA) results in complete remission in ~ 85% of newly diagnosed patients with acute myeloid leukemia (ND-AML), yet 30-40% experience relap
Publikováno v:
Nature cancer. 2(1)
Autor:
Chong Chyn Chua, Danielle Hammond, Andrew Kent, Ing Soo Tiong, Marina Y. Konopleva, Daniel A. Pollyea, Courtney D. DiNardo, Andrew H. Wei
Publikováno v:
Blood advances. 6(13)
The clinical benefit of adding venetoclax (VEN) to hypomethylating agents or low-dose cytarabine in older and/or unfit patients with newly diagnosed acute myeloid leukemia (AML) has been confirmed in phase 3 studies. With the increased uptake of VEN-